Copyright
©The Author(s) 2017.
World J Radiol. Sep 28, 2017; 9(9): 350-358
Published online Sep 28, 2017. doi: 10.4329/wjr.v9.i9.350
Published online Sep 28, 2017. doi: 10.4329/wjr.v9.i9.350
Figure 7 Resolving focal prostatic uptake in a 61-year-old man with Stage IV high-grade non-Hodgkin’s lymphoma and serum prostate-specific antigen of 2.
85 ng/mL. A: Fused PET/CT imaging performed after 2 cycles of chemotherapy shows focal uptake (arrowed) in the left side of the prostate at the level of the midgland on fused PET/CT; B: Repeat PET/CT performed 4 mo later following completing of 6 cycles of chemotherapy demonstrates resolution of this focal uptake. PET/CT: Positron emission tomography/computed tomography.
- Citation: Chetan MR, Barrett T, Gallagher FA. Clinical significance of prostate 18F-labelled fluorodeoxyglucose uptake on positron emission tomography/computed tomography: A five-year review. World J Radiol 2017; 9(9): 350-358
- URL: https://www.wjgnet.com/1949-8470/full/v9/i9/350.htm
- DOI: https://dx.doi.org/10.4329/wjr.v9.i9.350